State Street
VNRX icon

State Street’s VolitionRx Ltd VNRX Stock Holding History

State Street’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45.9K Sell
33,995
-2
-0% -$5 ﹤0.01% 4062
2026
Q1 		$137K Buy
33,997
+18,420
+118% +$88K ﹤0.01% 3972
2025
Q4 		$79.6K Buy
15,577
+2,145
+16% +$16.3K ﹤0.01% 4087
2025
Q3 		$182K Buy
13,432
+6,050
+82% +$80.5K ﹤0.01% 3932
2025
Q2 		$112K Hold
7,382
– – ﹤0.01% 3957
2025
Q1 		$84.2K Hold
7,382
– – ﹤0.01% 4003
2024
Q4 		$88.6K Buy
7,382
+1,186
+19% +$15.9K ﹤0.01% 4015
2024
Q3 		$74.5K Hold
6,196
– – ﹤0.01% 4035
2024
Q2 		$75K Hold
6,196
– – ﹤0.01% 4071
2024
Q1 		$93.8K Hold
6,196
– – ﹤0.01% 4039
2023
Q4 		$88.9K Hold
6,196
– – ﹤0.01% 4076
2023
Q3 		$85.4K Hold
6,196
– – ﹤0.01% 4148
2023
Q2 		$172K Hold
6,196
– – ﹤0.01% 4046
2023
Q1 		$237K Hold
6,196
– – ﹤0.01% 4017
2022
Q4 		$301K Buy
6,196
+430
+7% +$16.7K ﹤0.01% 3939
2022
Q3 		$157K Hold
5,766
– – ﹤0.01% 4243
2022
Q2 		$236K Hold
5,766
– – ﹤0.01% 4125
2022
Q1 		$347K Buy
5,766
+525
+10% +$29.8K ﹤0.01% 4188
2021
Q4 		$329K Hold
5,241
– – ﹤0.01% 4156
2021
Q3 		$325K Hold
5,241
– – ﹤0.01% 4153
2021
Q2 		$345K Sell
5,241
-16,114
-75% -$1.09M ﹤0.01% 3998
2021
Q1 		$1.61M Buy
21,355
+2,743
+15% +$235K ﹤0.01% 3514
2020
Q4 		$1.45M Buy
18,612
+5,660
+44% +$390K ﹤0.01% 3478
2020
Q3 		$831K Buy
12,952
+1,169
+10% +$79.5K ﹤0.01% 3489
2020
Q2 		$917K Buy
+11,783
New +$851K ﹤0.01% 3436
2020
Q1 		– Sell
-612
Closed -$58K – 3795
2019
Q4 		$58K Buy
+612
New +$63.5K ﹤0.01% 3716

Other funds holding VNRX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WANY
Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

State Street's VNRX Position: Q2 2026 in Review

State Street reduced its VolitionRx Ltd (VNRX) stake by 0.01% in Q2 2026, selling an estimated $5 and leaving 33,995 shares worth $45.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4062.

State Street first reported a position in VNRX in Q4 2019 and has held it in 26 quarters since. The position peaked at $1.61M in Q1 2021. 19 funds tracked by Wall St. Rank hold VNRX as of Q2 2026.

  • State Street held 33,995 shares of VolitionRx Ltd worth $45.9K as of Q2 2026.
  • State Street sold 2 VolitionRx Ltd shares in Q2 2026, an estimated $5.
  • VolitionRx Ltd made up ﹤0.01% of State Street's portfolio in Q2 2026, its #4062 holding.
  • State Street first reported a position in VolitionRx Ltd in Q4 2019 and has held it in 26 quarters since.
  • State Street's VolitionRx Ltd position peaked at $1.61M in Q1 2021.
  • 19 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.